The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons - PubMed (original) (raw)
. 1997 Dec 5;272(49):30662-71.
doi: 10.1074/jbc.272.49.30662.
Affiliations
- PMID: 9388201
- DOI: 10.1074/jbc.272.49.30662
Free article
The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons
S Mummidi et al. J Biol Chem. 1997.
Free article
Abstract
Human CC chemokine receptor 5 (CCR5), mediates the activation of cells by the chemokines macrophage inflammatory protein-1alpha, macrophage inflammatory protein-1beta, and RANTES, and serves as a fusion cofactor for macrophage-tropic strains of human immunodeficiency virus type 1. To understand the molecular mechanisms that regulate human CCR5 gene expression, we initiated studies to determine its genomic and mRNA organization. Previous studies have identified a single CCR5 mRNA isoform whose open reading frame is intronless. We now report the following novel findings. 1) Complex alternative splicing and multiple transcription start sites give rise to several distinct CCR5 transcripts that differ in their 5'-untranslated regions (UTR). 2) The gene is organized into four exons and two introns. Exons 2 and 3 are not interrupted by an intron. Exon 4 and portions of exon 3 are shared by all isoforms. Exon 4 contains the open reading frame, 11 nucleotides of the 5'-UTR and the complete 3'-UTR. 3) The transcripts appear to be initiated from two distinct promoters: an upstream promoter (PU), upstream of exon 1, and a downstream promoter (PD), that includes the "intronic" region between exons 1 and 3. 4) PU and PD lacked the canonical TATA or CAAT motifs, and are AT-rich. 5) PD demonstrated strong constitutive promoter activity, whereas PU was a weak promoter in all three leukocyte cell environments tested (THP-1, Jurkat, and K562). 6) We provide evidence for polymorphisms in the noncoding sequences, including the regulatory regions and 5'-UTRs. The structure of CCR5 was strikingly reminiscent of the overall structure of other chemokine/chemoattractant receptors, underscoring an important evolutionarily conserved function for a prototypical gene structure. This is the first description of functional promoters for any CC chemokine receptor gene, and we speculate that the complex pattern of splicing events and dual promoter usage may function as a versatile mechanism to create diversity and flexibility in the regulation of CCR5 expression.
Similar articles
- Gene organization and promoter function for CC chemokine receptor 5 (CCR5).
Guignard F, Combadiere C, Tiffany HL, Murphy PM. Guignard F, et al. J Immunol. 1998 Jan 15;160(2):985-92. J Immunol. 1998. PMID: 9551938 - Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus.
Mummidi S, Bamshad M, Ahuja SS, Gonzalez E, Feuillet PM, Begum K, Galvis MC, Kostecki V, Valente AJ, Murthy KK, Haro L, Dolan MJ, Allan JS, Ahuja SK. Mummidi S, et al. J Biol Chem. 2000 Jun 23;275(25):18946-61. doi: 10.1074/jbc.M000169200. J Biol Chem. 2000. PMID: 10747879 - Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage?
Turner JD, Schote AB, Macedo JA, Pelascini LP, Muller CP. Turner JD, et al. Biochem Pharmacol. 2006 Nov 30;72(11):1529-37. doi: 10.1016/j.bcp.2006.07.005. Epub 2006 Aug 22. Biochem Pharmacol. 2006. PMID: 16930562 Review. - Estrogen Receptor α Isoforms Generated by Alternative Use of Cryptic Exons.
Ishii H, Hattori Y, Ozawa H. Ishii H, et al. J Nippon Med Sch. 2023 Nov 7;90(5):364-371. doi: 10.1272/jnms.JNMS.2023_90-507. Epub 2023 Aug 8. J Nippon Med Sch. 2023. PMID: 37558429 Review.
Cited by
- Narrowing the Relationship between Human CCR5 Gene Polymorphisms and Chagas Disease: Systematic Review and Meta-Analysis.
Ferreira JM, Santos BRCD, Moura EL, Santos ACMD, Vencioneck Dutra JC, Figueiredo EVMS, Lima Filho JL. Ferreira JM, et al. Life (Basel). 2023 Aug 2;13(8):1677. doi: 10.3390/life13081677. Life (Basel). 2023. PMID: 37629534 Free PMC article. - Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A, Paneerselvam N, Lawson BR. Khan A, et al. Clin Immunol. 2023 Oct;255:109741. doi: 10.1016/j.clim.2023.109741. Epub 2023 Aug 21. Clin Immunol. 2023. PMID: 37611838 Free PMC article. Review. - PlmCas12e (CasX2) cleavage of CCR5: impact of guide RNA spacer length and PAM sequence on cleavage activity.
Armstrong DA, Hudson TR, Hodge CA, Hampton TH, Howell AL, Hayden MS. Armstrong DA, et al. RNA Biol. 2023 Jan;20(1):296-305. doi: 10.1080/15476286.2023.2221510. RNA Biol. 2023. PMID: 37287312 Free PMC article. - CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY.
Armstrong DA, Hudson TR, Hodge CA, Hampton TH, Howell AL, Hayden MS. Armstrong DA, et al. bioRxiv [Preprint]. 2023 Jan 2:2023.01.02.522476. doi: 10.1101/2023.01.02.522476. bioRxiv. 2023. PMID: 36711562 Free PMC article. Updated. Preprint. - Host polymorphisms and COVID-19 infection.
Delanghe JR, Speeckaert MM. Delanghe JR, et al. Adv Clin Chem. 2022;107:41-77. doi: 10.1016/bs.acc.2021.07.002. Epub 2021 Aug 23. Adv Clin Chem. 2022. PMID: 35337605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases